Depending on individual effectiveness and tolerance, the dose may be increased to 0.5 mg weekly after the initial period, and further to 1 mg or 2 mg if needed
Conclusion After a temporary slowdown, FDA has resumed aggressive, batchstyle enforcementagain targeting how compounded GLP1 products are marketed through telehealth channels
But it overlooks how these medicines work in practice
Medication injected into lumpy tissue may not absorb consistently, which can lead to unpredictable blood sugar levels, especially for patients who also take insulin along with GLP-1
There are some caveats, though, and for balance I will also look at a big new safety study, Xie et al , that pushes back but only a bit
Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis